Design, Synthesis, Inhibiting HDACs Ability and Antitumor Activity of Pyrimidin-4（3H）-one Hydroxamate Derivatives
Design, Synthesis, Inhibiting HDACs Ability and Antitumor Activity of Pyrimidin-4（3H）-one Hydroxamate Derivatives
摘要
A series of novel pyrimidin-4（3H）-one hydroxamate derivatives was designed, synthesized and studied for their activities against histone deacetylases（HDACs）. The results indicate that all the compounds show HDACs inhibitiory activity. The antiproliferative activities of the compounds against HeLa and A549 cells were also investigated. The pharmacological results show compound 9g has potent activity in the enzymatic inhibition assay and cell-based assay.
A series of novel pyrimidin-4（3H）-one hydroxamate derivatives was designed, synthesized and studied for their activities against histone deacetylases（HDACs）. The results indicate that all the compounds show HDACs inhibitiory activity. The antiproliferative activities of the compounds against HeLa and A549 cells were also investigated. The pharmacological results show compound 9g has potent activity in the enzymatic inhibition assay and cell-based assay.
基金
Supported by the National Natural Science Foundation of China（No.31540082）.
参考文献20
-
1Bameda-Zahonero B., Parra M., :viol. Oncol., 2012, 6(6), 579.
-
2Kristensen L. S., Nielsen H. M., Hansen L. L., Eur. J. Pharmacol., 2009, 625, 131.
-
3Hoshino I., Matsubara H., Surg. Today, 2010, 40(9), 809.
-
4Marks E, Ritkind R. A., Richon V. M., Breslow R., Miller T., Kelly W. K., Nat. Rev. Cancer, 2001, 1(3), 194.
-
5Bolden J. E., Peart M. J., Johnstone R. W., Nat. Rev. Drug Discov., 2006, 5(9), 769.
-
6Witt O., Deubzer H. E., Milde T., Oehme I., Cancer Lett., 2009, 277(1), 8.
-
7Marks E A., Rifkind R. A., Richon V. M., Breslow R., Clin. Cancer Res., 2001, 7(4), 759.
-
8Minucei S., Pellici E G., Nat. Rev. Cancer, 2006, 6(1), 38.
-
9Wilson A. J., Byun D. S., Popova N., Murray L. B., L'Italien K., So- wa Y., Arango D., Velcich A., Augenlicht L. H., Madadason J. M., J. Biol. Chem., 2006, 281(19), 13548.
-
10Zhu E, Martin E., Mengwasser J., Sehlag E, Janssen K. E, Gottlicher M., Cancer Cell, 2004, 5(5), 455.
-
1朱则善,颜志森,赵崇涛,张晓勤,陈古镛.异羟肟酸比色法测定电解混合液中葡萄糖酸的含量[J].福建师范大学学报（自然科学版）,1991,7(4):45-48. 被引量：2
-
2Shu Lan Zhang Xin Zhai Shi Jiao Zhang Hong Hao Yu Ping Gong.Synthesis and cytotoxicity studies of quinoline-3-carbonitrile derivatives[J].Chinese Chemical Letters,2010,21(8):939-942.
-
3李燕,刘晓艳,张顺,刘亭,李勇军,兰燕宇,王爱民,王永林,何彬.一种香豆素荧光标记多肽的合成及应用[J].应用化学,2014,31(12):1413-1418. 被引量：3
-
4孙辉,黄浩,周伟澄.N-羟基-3-(取代苯基)-(2E)-2-丙烯酰胺的合成和HDAC抑制活性[J].中国医药工业杂志,2016,47(6):682-684.
-
5LI Xiao-hui WEI Ying-dong WANG Shi-miao WANG Meng-nan HUANG Da-wei XIU Zhi-long.Synthesis,Biological Evaluation and Molecular Modeling of Cyclic Tetrapeptide Based Inhibitors HDAC[J].Chemical Research in Chinese Universities,2012,28(6):1011-1016.
-
6LIU Yazhou,HUANG Lan,SUN Qianyun,ZHANG Maosheng,LI Tianlei,LIANG Guangyi,PAN Weidong.Syntheses and Anti-cancer Activities of Derivatives of Tetrandrine and Fangchinoline[J].Chemical Research in Chinese Universities,2014,30(6):937-940. 被引量：3
-
7相玉红,蒋大鹏,张卓勇.苯酰胺类组蛋白去乙酰化酶抑制剂的分子对接及三维定量构效关系研究[J].计算机与应用化学,2009,26(11):1371-1379. 被引量：3
-
8张晓,杨蓉,王琛,衡成林.功能化氧化石墨烯的细胞相容性(英文)[J].物理化学学报,2012,28(6):1520-1524. 被引量：12
-
9我国原创抗癌新药西达苯胺获准全球上市[J].生物学教学,2015,40(7):76-76.
-
10章媛,陈亚东,尤启冬,邹丽云,杨燕.同源模建和分子对接研究HDAC1/HDAC8的选择性[J].物理化学学报,2010,26(6):1676-1686. 被引量：3
